Arseus makes three acquisitions
BRUSSELS Nov 13 (Reuters) - Belgo-Dutch medical supplies firm Arseus said on Tuesday it has made three acquisitions in its drug ingredients business Fagron as it seeks to capitalise on the growth of drug compounding, where pharmacists mix up their own medications.
The acquisitions, in Brazil, Colombia and Scandinavia, will generate a combined annual turnover of about 12 million euros ($15.25 million) in 2012 and an EBITDA margin of 25 percent. ($1 = 0.7867 euros) (Reporting By Ben Deighton)
- With no sign of missing plane, search spreads far across land and sea |
- Malaysia military source says missing jet veered to west |
- Toddler found with heroin at New Jersey daycare center
- UPDATE 1-Missing Malaysian plane last seen at Strait of Malacca-source
- Ukraine appeals to the West as Crimea turns to Russia |